Email
Print
Live Discussion
More Question and Answer sessions will be scheduled soon. Check back!
TMA's Live Discussion Series is not your typical chat program! Click here to learn how to participate.
Upcoming Discussions
Wednesday, Oct 15, 4:00-5:00 PM EST
Interstitial Lung Disease (ILD)
Chet Oddis, M.D., answers questions on Interstitial Lung Disease.
Click here to submit your questions early.
Interstitial Lung Disease (ILD)
Chet Oddis, M.D., answers questions on Interstitial Lung Disease.
Click here to submit your questions early.
Past Discussions
Friday, Feb 22, 3:00-4:00 PM EST
Topics from Juvenile Myositis
Lisa G. Rider, M.D., TMA medical advisor and Deputy Chief of NIEHS, National Institutes of Health, is a pediatric rheumatologist who has been closely associated with TMA since its beginning.
Dr. Rider has made Juvenile Myositis her life's work and has spent over 15 years in the field. She is involved with research into many aspects of Juvenile Myositis, has counseled families dealing with very difficult cases of JM and has played a significant part in the lives of JM families around the world. She was a driving force and a lead editor in the publication of "Myositis and You," the landmark compilation of medical information and coping skills for the juvenile myositis community. Dr. Rider is currently participating in JM research studies related to twin siblings, rituximab, and calcinosis, among others. Click here to read the transcript.
Topics from Juvenile Myositis
Lisa G. Rider, M.D., TMA medical advisor and Deputy Chief of NIEHS, National Institutes of Health, is a pediatric rheumatologist who has been closely associated with TMA since its beginning.
Dr. Rider has made Juvenile Myositis her life's work and has spent over 15 years in the field. She is involved with research into many aspects of Juvenile Myositis, has counseled families dealing with very difficult cases of JM and has played a significant part in the lives of JM families around the world. She was a driving force and a lead editor in the publication of "Myositis and You," the landmark compilation of medical information and coping skills for the juvenile myositis community. Dr. Rider is currently participating in JM research studies related to twin siblings, rituximab, and calcinosis, among others. Click here to read the transcript.
Monday, Apr 7, 3:00-4:00 PM EST
Myositis and Cancer: what's the connection?
Andrew Mammen, MD, PhD, is an Assistant Professor of Neurology at Johns Hopkins University in Baltimore and Co-Director of The Johns Hopkins Myositis Center. Dr. Mammen has a special interest in the inflammatory myopathies, and his research focuses primarily on muscle regeneration in myositis as well as the link between myositis and cancer.
Dr. Mammen spoke at last year's Annual Conference about the relationship between dermatomyositis and polymyositis and cancer, and was a member of the medical panel at the conference. Click here to read the transcript.
Myositis and Cancer: what's the connection?
Andrew Mammen, MD, PhD, is an Assistant Professor of Neurology at Johns Hopkins University in Baltimore and Co-Director of The Johns Hopkins Myositis Center. Dr. Mammen has a special interest in the inflammatory myopathies, and his research focuses primarily on muscle regeneration in myositis as well as the link between myositis and cancer.
Dr. Mammen spoke at last year's Annual Conference about the relationship between dermatomyositis and polymyositis and cancer, and was a member of the medical panel at the conference. Click here to read the transcript.
Tuesday, May 13, 3:00-4:00 PM EST
Side-Effects of Medications
Robert L. Wortmann, M.D. is a nationally recognized Rheumatologist and is Professor of Medicine in the Section of Rheumatology at the Dartmouth Hitchcock Medical Center in Lebanon, NH. He has a long standing interest in "diseases of skeletal muscle," having edited a textbook with that title. Dr. Wortmann currently serves as the Chairman of TMA’s Medical Advisory Board.
Dr. Wortmann will answer questions regarding the side-effects of medications. You are encouraged to submit your questions early. Click here to read the transcript.
Side-Effects of Medications
Robert L. Wortmann, M.D. is a nationally recognized Rheumatologist and is Professor of Medicine in the Section of Rheumatology at the Dartmouth Hitchcock Medical Center in Lebanon, NH. He has a long standing interest in "diseases of skeletal muscle," having edited a textbook with that title. Dr. Wortmann currently serves as the Chairman of TMA’s Medical Advisory Board.
Dr. Wortmann will answer questions regarding the side-effects of medications. You are encouraged to submit your questions early. Click here to read the transcript.
Monday, Jun 16, 3:00-4:00 PM EST
Myositis and statins
Lisa Christopher-Stine, MD, MPH, Co-Director of The Johns Hopkins Myositis Center will speak about the relationship between statins (drugs prescribed for high cholesterol) and myositis in a live "Question & Answer" discussion.
A clinical rheumatologist, Dr. Christopher-Stine first became interested in myositis when she began seeing several cases in her practice. Dr. Christopher-Stine currently works with myositis patients as Co-Director of the John's Hopkins Myositis Center and serves as an Assistant Professor of Medicine at John Hopkins University. Click here to read the transcript.
Myositis and statins
Lisa Christopher-Stine, MD, MPH, Co-Director of The Johns Hopkins Myositis Center will speak about the relationship between statins (drugs prescribed for high cholesterol) and myositis in a live "Question & Answer" discussion.
A clinical rheumatologist, Dr. Christopher-Stine first became interested in myositis when she began seeing several cases in her practice. Dr. Christopher-Stine currently works with myositis patients as Co-Director of the John's Hopkins Myositis Center and serves as an Assistant Professor of Medicine at John Hopkins University. Click here to read the transcript.
Thursday, Aug 21, 3:00-4:00 PM EST
Dysphagia
Todd Levine has been working with myositis patients for over 15 year. He’s published and conducted research with all forms of myositis and he is also currently involved with the IBM in lithium trials as well as Rituximab in PM/DM and MedImmune for DM studies.
Dr. Levine has been involved in the treatment of dyshagia not only in the myositis but also in patients with Lou Gherig’s disease. In fact, he authored the introduction to the Dysphagia Cookbook which is available in TMA’s online marketplace. Click here to read the transcript.
Dysphagia
Todd Levine has been working with myositis patients for over 15 year. He’s published and conducted research with all forms of myositis and he is also currently involved with the IBM in lithium trials as well as Rituximab in PM/DM and MedImmune for DM studies.
Dr. Levine has been involved in the treatment of dyshagia not only in the myositis but also in patients with Lou Gherig’s disease. In fact, he authored the introduction to the Dysphagia Cookbook which is available in TMA’s online marketplace. Click here to read the transcript.